REFERENCES
- Allam MF, Del Castillo AS, Díaz-Molina C, Navajas RF. Invasive
pulmonary aspergillosis: identification of risk factors. Scand J
Infect Dis. 2002;34(11):819-22. doi: 10.1080/0036554021000026954.
PMID: 12578151.
- Geltner C, Lass-Flörl C. Invasive pulmonary Aspergillosis in organ
transplants–Focus on lung transplants. RespirInvestig. 2016
Mar;54(2):76-84. doi: 10.1016/j.resinv.2015.08.005. Epub 2015 Nov 10.
PMID: 26879476.
- Singh N. Fungal infections in the recipients of solid organ
transplantation. Infect Dis Clin North Am 2003;17(1):113–34
- deVrankrijker AM, van der Ent CK, van Berkhout FT, Stellato RK,
Willems RJ, Bonten MJ, Wolfs TF. Aspergillus fumigatus colonization in
cystic fibrosis: implications for lung function? ClinMicrobiol Infect.
2011 Sep;17(9):1381-6. doi: 10.1111/j.1469-0691.2010.03429.x. Epub
2010 Dec 16. PMID: 21087348.
- Burgel PR, Paugam A, Hubert D, Martin C. Aspergillus
fumigatus in the cystic fibrosis lung: pros and cons of azole
therapy. Infect Drug Resist . 2016;9:229-238. Published 2016 Sep
20. doi:10.2147/IDR.S63621
- Garcia-Vidal C, Alastruey-Izquierdo A, Aguilar-Guisado M, Carratalà J,
Castro C, Fernández-Ruiz M, Aguado JM, Fernández JM, Fortún J,
Garnacho-Montero J, Gavaldà J, Gudiol C, Guinea J, Gómez-López A,
Muñoz P, Pemán J, Rovira M, Ruiz-Camps I, Cuenca-Estrella M. Executive
summary of clinical practice guideline for the management of invasive
diseases caused by Aspergillus: 2018 Update by the
GEMICOMED-SEIMC/REIPI. EnfermInfeccMicrobiolClin. 2019
Oct;37(8):535-541. English, Spanish. doi: 10.1016/j.eimc.2018.03.018.
Epub 2018 Jun 28. PMID: 29960829.
- Gubbins PO, Amsden JR. Drug-drug interactions of antifungal agents and
implications for patient care. Expert OpinPharmacother. 2005
Oct;6(13):2231-43. doi: 10.1517/14656566.6.13.2231. PMID: 16218884.
- Wang T, Zhu H, Sun J, Cheng X, Xie J, Dong H, Chen L, Wang X, Xing J,
Dong Y. Efficacy and safety of voriconazolee and CYP2C19 polymorphism
for optimised dosage regimens in patients with invasive fungal
infections. Int J Antimicrob Agents. 2014 Nov;44(5):436-42. doi:
10.1016/j.ijantimicag.2014.07.013. Epub 2014 Aug 30. PMID: 25239277.
- Felton T, Troke PF, Hope WW. Tissue penetration of antifungal agents.
Clin Microbiol Rev. 2014 Jan;27(1):68-88. doi: 10.1128/CMR.00046-13.
PMID: 24396137; PMCID: PMC3910906.
- Monforte V, Ussetti P, Gavaldà J, Bravo C, Laporta R, Len O,
García-Gallo CL, Tenorio L, Solé J, Román A. Feasibility,
tolerability, and outcomes of nebulized liposomal amphotericin B for
Aspergillus infection prevention in lung transplantation. J Heart Lung
Transplant. 2010 May;29(5):523-30. doi: 10.1016/j.healun.2009.11.603.
Epub 2010 Jan 12. PMID: 20061165.
- Tolman JA, Nelson NA, Son YJ, Bosselmann S, Wiederhold NP, Peters JI,
McConville JT, Williams RO 3rd. Characterization and pharmacokinetic
analysis of aerosolized aqueous voriconazole solution. Eur J Pharm
Biopharm. 2009 May;72(1):199-205. doi: 10.1016/j.ejpb.2008.12.014.
PMID: 19348016.
- Le J, Ashley ED, Neuhauser MM, Brown J, Gentry C, Klepser ME, et al.
Consensus summary of aerosolized antimicrobial agents: application of
guideline criteria. Insights from the Society of Infectious Diseases
Pharmacists. Pharmacotherapy. 2010;30(6):562-84. DOI:
10.1592/phco.30.6.562
- Guía de buenas prácticas de preparación de medicamentos en servicios
de farmacia hospitalaria. MINISTERIO DE SANIDAD, SERVICIOS SOCIALES E
IGUALDAD.2014. Available at:https://www.sefh.es/sefhpdfs/GuiaBPP_JUNIO_2014_VF.pdf
- Dupuis A, Tournier N, Le Moal G, Venisse N. Preparation and stability
of voriconazolee eye drop solution. Antimicrob Agents Chemother 2009;
53, 2: 798-799.
- Amorós-Reboredo P, Bastida-Fernandez C, Guerrero-Molina L, Soy-Muner
D, López-Cabezas C. Stability of frozen 1% voriconazolee ophthalmic
solution. Am J Health-Syst Pharm ; 72:479-482 2015
- Sahraoui L, Chiadmi F, Schlatter J, Toledano A, Cisternino S, Fontan
JE. Stability of voriconazolee injection in 0.9% sodium chloride and
5% dextrose injections. Am J Health-SystPharm ; 63: 1423-1426. 2006
- Adams, A.I.H., Morimoto, L.N., Meneghini, L.Z., Bergold, A.M.
Treatment of invasive fungal infections: Stability of voriconazole
infusion solutions in PVC bags. BJID ; 12, 5: 400-404. 2008
- Holle J, Leichsenring M, Meissner PE. Nebulized voriconazole in
infections with Scedosporiumapiospermum–case report and review of
the literature. J Cyst Fibros. 2014 Jul;13(4):400-2. doi:
10.1016/j.jcf.2013.10.014. Epub 2013 Nov 18. PMID: 24263169.
- Hilberg O, Andersen CU, Henning O, Lundby T, Mortensen J, Bendstrup E.
Remarkably efficient inhaled antifungal monotherapy for invasive
pulmonary aspergillosis. EurRespir J. 2012 Jul;40(1):271-3. doi:
10.1183/09031936.00163511. PMID: 22753838.